Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 11/20 | 0.44 |
| ▸ | CA1 | P00915 | 9/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 8/20 | 0.43 |
| ▸ | CA12 | O43570 | 5/20 | 0.43 |
| ▸ | MIF | P14174 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10603244 | 0.91 | CA2 (0.46) | CA2CA1CA7CA4CA9 | |
| SCHEMBL15572316 | 0.91 | AKR1C3 (0.58) | AKR1C3PTGS2 | |
| SCHEMBL8430221 | 0.88 | AKR1C3 (0.45) | AKR1C3MIFCES2 | |
| SCHEMBL8521003 | 0.85 | PTGS2 (0.45) | AKR1C3CA2CA1CA7CA4 | |
| SCHEMBL15570465 | 0.84 | AKR1C3 (0.39) | AKR1C3MIFCES2 | |
| SCHEMBL8428757 | 0.83 | MIF (0.44) | CA2CA1CA7CA4CA9 | |
| SCHEMBL8431937 | 0.83 | MIF (0.44) | CA2CA1CA7CA4CA9 | |
| SCHEMBL8431678 | 0.83 | MIF (0.44) | CA2CA1CA7CA4CA9 | |
| SCHEMBL8435180 | 0.82 | AKR1C3 (0.49) | AKR1C3MIFCES2 | |
| SCHEMBL8432320 | 0.82 | CA2 (0.41) | CA2CA1CA7CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5965619-A | ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION | CELL PATHWAYS INC. (US) | 1999-10-12 | — | — | US | disclosed |
| EP-0142801-B1 | INDENE DERIVATIVES USEFUL AS PAF-ANTAGONISTS | MERCK & CO. INC. (US) | 1989-05-31 | — | — | EP | disclosed |
| US-4656190-A | PLATELET ACTIVATING FACTOR | MERCK & CO., INC. (US) | 1987-04-07 | — | — | US | disclosed |
| EP-0142801-A2 | Indene derivatives useful as paf-antagonists | MERCK & CO. INC. (US) | 1985-05-29 | — | — | EP | disclosed |